Preliminary revenue for the first quarter was below the company's expectations due to an increasing number of customers delaying instrument purchases and softness in consumable shipments. All regions ...
Pacific Biosciences of California is a biotechnology company specializing in genetic sequencing for healthcare, agriculture, and environmental science. PACB's acquisition of Apton Biosystems aims to ...
Collectively, these enhancements will enable each Revio instrument to sequence up to 2,500 human whole genomes per year at a cost of just under $500 per human genome. "Increased yields and reduced ...
SINGAPORE, July 12, 2023/EINPresswire.com/ -- Next Level Genomics Pte Ltd, a Singapore-based provider of advanced genomics solutions to researchers and clinician ...
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its continued focus on research and development and a robust product portfolio. The optimism, led by a ...
When GEN spoke with Christian Henry, CEO of PacBio, before last year’s American Society of Human Genetics (ASHG) conference being held in Los Angeles, his excitement was palpable. The company was ...
MENLO PARK, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced SPRQ, an improved sequencing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback